LAS VEGAS (MedPage Today) -- Although it missed its primary endpoint, a phosphodiesterase inhibitor may have some effects in diabetic nephropathy, researchers reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment